Glaxo to Pay $1 Billion to Children with Birth Defects from Mothers who took Paxil

more+
less-

Bloomberg News reported that GlaxoSmithKline P.L.C. has agreed to pay $1 billion to injured consumers to resolve more than 800 cases involving the antidepressant Paxil. The medication has been in use in the U.S. since 1992. Paxil generated about $793 million in sales in 2009 alone which was about 1.8 percent of Glaxo’s total revenue. Glaxo reported U.S. sales exceeding $11 billion since 1997.

Please see full article below for more information.

LOADING PDF: If there are any problems, click here to download the file.

Topics:  Birth Defects, Drug Safety, Pharmaceutical, Pregnancy, Prescription Drugs, Side Effects

Published In: Civil Remedies Updates, Health Updates, Products Liability Updates

DISCLAIMER: Because of the generality of this update, the information provided herein may not be applicable in all situations and should not be acted upon without specific legal advice based on particular situations.

© Regan, Zambri & Long, PLLC | Attorney Advertising

Don't miss a thing! Build a custom news brief:

Read fresh new writing on compliance, cybersecurity, Dodd-Frank, whistleblowers, social media, hiring & firing, patent reform, the NLRB, Obamacare, the SEC…

…or whatever matters the most to you. Follow authors, firms, and topics on JD Supra.

Create your news brief now - it's free and easy »